Author:
Sader Helio S.,Farrell David J.,Flamm Robert K.,Jones Ronald N.
Subject
Infectious Diseases,Microbiology (medical)
Reference19 articles.
1. In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance;Bulik;Antimicrob Agents Chemother,2010
2. Antimicrobial activity of ceftolozane/tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. hospitals (2011–2012);Farrell;Antimicrob Agents Chemother,2013
3. Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes;Sader;Antimicrob Agents Chemother,2011
4. In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum beta-lactamases, in the thighs of neutropenic mice;Craig;Antimicrob Agents Chemother,2013
5. Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with ceftolozane;Vanscoy;Antimicrob Agents Chemother,2013
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献